AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)

Q: What does CUSIP 00288U106 represent in this 13F holders report?

CUSIP 00288U106 is the security identifier for ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share used to aggregate holder disclosures.

Q: How many institutions held ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share in Q3 2021?

115 institutional investors reported ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share for Q3 2021. Use the holders table for investor-level position and value details.

CUSIP: 00288U106

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class: Equity / Common Shares, no par value per share
Shares outstanding: 305,667,944
Total 13F shares: 98,697,276
Share change: +8,153,211
Total reported value: $1,977,505,786
Put/Call ratio: 51%
Price per share: $20.04
Number of holders: 115
Value change: +$155,909,310
Number of buys: 74
Number of sells: 49

Quarterly Holders Quick Answers

What is CUSIP 00288U106?
CUSIP 00288U106 identifies ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2021
Previous quarter: Q2 2021

Recent filing periods for CUSIP 00288U106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital World Investors	13F	Company	4.4%	13,415,437	$295,140,000	—	30 Jun 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	3.4%	10,450,180	$229,904,000	—	30 Jun 2021	13F
Allianz Asset Management GmbH	13F	Company	3.2%	9,929,704	$218,454,000	—	30 Jun 2021	13F
SB Management Ltd	13F	Company	3.2%	9,817,190	$215,978,000	—	30 Jun 2021	13F
Capital International Investors	13F	Company	2.3%	6,894,089	$151,670,000	—	30 Jun 2021	13F
ORBIMED ADVISORS LLC	13F	Company	2%	6,223,019	$136,906,000	—	30 Jun 2021	13F
HARVARD MANAGEMENT CO INC	13F	Company	1.3%	4,105,095	$90,312,000	—	30 Jun 2021	13F
Founders Fund VII Management, LLC	13F	Company	1.2%	3,773,530	$83,018,000	—	30 Jun 2021	13F
GUARDIAN CAPITAL ADVISORS LP	13F	Company	1.3%	3,975,994	$81,428,000	—	30 Jun 2021	13F
BAILLIE GIFFORD & CO	13F	Company	0.89%	2,725,197	$59,954,000	—	30 Jun 2021	13F
CREDIT SUISSE AG/	13F	Company	0.86%	2,635,773	$57,987,000	—	30 Jun 2021	13F
John Hamer	3/4/5	Director	— class O/S missing	14,734,623	$39,783,482	—	31 Aug 2021	3/4/5
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.49%	1,500,000	$33,000,000	—	30 Jun 2021	13F
Alpha Wave Global, LP	13F	Company	0.44%	1,338,253	$29,442,000	—	30 Jun 2021	13F
Intellectus Partners, LLC	13F	Company	0.39%	1,206,979	$26,554,000	—	30 Jun 2021	13F
Capital International, Inc./CA/	13F	Company	0.32%	964,643	$21,222,000	—	30 Jun 2021	13F
BlackRock Finance, Inc.	13F	Company	0.29%	897,187	$19,738,000	—	30 Jun 2021	13F
Swedbank AB	13F	Company	0.28%	851,150	$18,725,300	—	30 Jun 2021	13F
CLOUGH CAPITAL PARTNERS L P	13F	Company	0.23%	698,800	$15,374,000	—	30 Jun 2021	13F
MORGAN STANLEY	13F	Company	0.19%	574,193	$12,633,000	—	30 Jun 2021	13F
Laurion Capital Management LP	13F	Company	0.15%	450,000	$9,900,000	—	30 Jun 2021	13F
Novo Holdings A/S	13F	Company	0.14%	422,382	$9,292,000	—	30 Jun 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.13%	403,609	$8,879,000	—	30 Jun 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.13%	403,200	$8,870,000	—	30 Jun 2021	13F
Woodline Partners LP	13F	Company	0.13%	396,816	$8,730,000	—	30 Jun 2021	13F
FEDERATED HERMES, INC.	13F	Company	0.13%	396,000	$8,712,000	—	30 Jun 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.12%	377,216	$8,299,000	—	30 Jun 2021	13F
Blackstone Inc.	13F	Company	0.11%	350,000	$7,700,000	—	30 Jun 2021	13F
Cardinal Point Wealth Management LLC	13F	Company	0.1%	310,120	$6,823,000	—	30 Jun 2021	13F
Aberdeen Group plc	13F	Company	0.1%	300,428	$6,614,000	—	30 Jun 2021	13F
MARSHALL WACE, LLP	13F	Company	0.09%	273,279	$6,011,000	—	30 Jun 2021	13F
Cubist Systematic Strategies, LLC	13F	Company	0.09%	260,359	$5,728,000	—	30 Jun 2021	13F
Temasek Holdings (Private) Ltd	13F	Company	0.08%	236,798	$5,210,000	—	30 Jun 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.08%	232,826	$5,122,000	—	30 Jun 2021	13F
Alyeska Investment Group, L.P.	13F	Company	0.07%	225,000	$4,950,000	—	30 Jun 2021	13F
HAMILTON LANE ADVISORS LLC	13F	Company	0.07%	201,381	$4,430,000	—	30 Jun 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	198,738	$4,372,000	—	30 Jun 2021	13F
Ergoteles LLC	13F	Company	0.06%	183,336	$4,033,000	—	30 Jun 2021	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.06%	174,428	$3,837,000	—	30 Jun 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.05%	158,847	$3,495,000	—	30 Jun 2021	13F
ROYAL BANK OF CANADA	13F	Company	0.05%	153,577	$3,379,000	—	30 Jun 2021	13F
Belmont Capital, LLC	13F	Company	0.05%	150,000	$3,300,000	—	30 Jun 2021	13F
Monashee Investment Management LLC	13F	Company	0.04%	135,000	$2,970,000	—	30 Jun 2021	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.04%	118,903	$2,616,000	—	30 Jun 2021	13F
Jump Financial, LLC	13F	Company	0.04%	116,800	$2,570,000	—	30 Jun 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.04%	114,721	$2,523,000	—	30 Jun 2021	13F
Pentwater Capital Management LP	13F	Company	0.04%	112,500	$2,475,000	—	30 Jun 2021	13F
Ester Falconer	3/4/5	Chief Technology Officer	— mixed-class rows	1,750,000 mixed-class rows	$2,362,500	—	23 Sep 2021	3/4/5
Bank of New York Mellon Corp	13F	Company	0.03%	88,971	$1,957,000	—	30 Jun 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	86,716	$1,908,000	—	30 Jun 2021	13F

Institutional Holders of AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) as of Q3 2021

As of 30 Sep 2021, AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) was held by 115 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 98,697,276 shares. The largest 10 holders included Capital World Investors, Allianz Asset Management GmbH, BAKER BROS. ADVISORS LP, SB Management Ltd, Capital International Investors, ORBIMED ADVISORS LLC, HARVARD MANAGEMENT CO INC, GUARDIAN CAPITAL ADVISORS LP, Founders Fund VII Management, LLC, and BAILLIE GIFFORD & CO. This page lists 115 institutional shareholders reporting positions in this security for the Q3 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders

111

Q3 2021 holders

115

Holder diff

Investor	Q2 2021 Shares	Q3 2021 Shares	Share Diff	Share Chg %	Q2 2021 Value $	Q3 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.